Our work not only provides novel insight into the neuroprotective effects of knockdown of ArgRS but also suggests that knockdown of ArgRS-induced antioxidant stress and the improvement of mitochondrial function and glucose metabolism could be potential therapeutic strategies for protecting ischemic stroke. This evidence concerns the gene RARS1 and ischemic stroke.